From K-pop to Rock and Trot, 40 Acts Set to Perform… Two-Day Lineup for ‘2026 KGMA’ Revealed
To be held at Gocheok Sky Dome on November 7–8
A total of 40 teams—20 teams each day—took the stage
ATEEZ, RISE, Young K, and Others Set to Debut
Won Yi and Nam Ji-hyun, with Liz and Kim Jae-won as hosts
[Edaily Starin YUN GI BACK Reporter] The “2026 Korea Grand Music Awards” (2026 KGMA) has unveiled its two-day lineup, featuring artists ranging from K-pop to rock bands and trot singers. (Photo courtesy of the KGMA Organizing Committee) The KGMA Organizing Committee announced on the 22nd the daily lineups for the “3rd Korea Grand Music Awards,” which will be held on November 7–8 at Gocheok Sky Dome in Guro-gu, Seoul. A total of 40 acts—20 per day—will take the stage. On the 7th, designated as “Artist Day,” performers will include Nobel Bright, Nueara, Dayoung, Lucy, Lisenne, Maydin, Miyao, Cykerus, I-DIT, Andable, Young K, All Day Project, Jang Min-ho, CRAVITY, Close Your Eyes, TUID, TREASURE, Triple S, P1Harmony, and Fifty Fifty (listed in alphabetical order) will perform. The lineup stands out for its wide range, spanning bands, trot, and K-pop. Young K—a member of DAY6 who is also active as a solo artist—will take the stage alongside the band Lucy and trot singer Jang Min-ho. Also joining the lineup are Lisenne, who recently made a comeback on the music charts, All Day Project—returning to the KGMA for the second time following last year’s appearance—and Dayoung. Groups actively performing both domestically and internationally—such as CRAVITY, TREASURE, Triple S, P1Harmony, and Fifty Fifty—as well as rising stars like Nueara, Maydin, Miyao, Cyker, I-DIT, Andable, Close Your Eyes, and Tuid will fill the stage on the first day. On the 8th, designated as “Music Day,” NEXZ, RISE, Minho, Park Ji-hyun, BILLIE, Shownu X Hyungwon, Ahop, Alpha Drive One, A.N., ATEEZ, Wayzone V, Yuna, ITZY, Choi Ye-na, Kiss of Life, Kiki, Kickflip, Touched, TOURS, and Hearts to Hearts will take the stage. On the second day, a large number of groups that have expanded their reach on the global stage—including ATEEZ and RISE, as well as ITZY, Way V, and TOURS—are lined up. SHINee’s Minho and ITZY’s Yuna are listed as solo artists, while MONSTA X’s Shownu X Hyungwon will take the stage as a unit. Joining them are girl groups such as BILLIE, Kiss of Life, Kiki, and Hearts to Hearts, as well as rising stars like Ahop, Alpha Drive One, A.N., and Kickflip. The band Touched, trot singer Park Ji-hyun, and solo artist Choi Ye-na will also appear, broadening the range of genres represented. The show will be hosted by Lisenne’s Won-i and actress Nam Ji-hyun on the 7th, and by IVE’s Liz and actor Kim Jae-won on the 8th. A total of 39 individuals—including Go Yoon-jung, Kwak Sun-young, Kim Hyang-gi, Na In-woo, Noh Jeong-eui, Moon Sang-min, Arin, Won Ji-an, Lee Min-ki, Lee Sun-bin, Lee Ju-bin, Lee Jun-ho, Lee Chae-min, Jeon Yeo-bin, Jung Kyung-ho, Jo Yi-hyun, Cha Jun-hwan, Chae Jong-hyeop, Choi Hyun-wook, and Han Sun-hwa—will attend as presenters. The “2026 KGMA” is hosted by Ilgan Sports (Edaily M) and co-organized by the KGMA Organizing Committee and Creatoring. Digital and physical sales data will be provided by Hanteo Chart, Genie Music, FLO, and Bugs, while the official fan voting will take place on the Kugung app. The awards ceremony will be broadcast live on ENA. In Japan, it will be streamed live on Hulu Japan, and in regions outside of Japan and China, it will be streamed live on TikTok Live.
Lisa Su, Chairwoman and CEO of AMD, concluded a meeting lasting over three hours with Jeon Young-hyun, President and CEO of SamsungElectronics and Vice Chairman in charge of the Device Solutions (DS) …
Epfeglenatide, developed by HanmiPharm, has received approval from the Ministry of Food and Drug Safety as the first domestically developed GLP-1-based obesity treatment. With this approval, Korea has…
A new domestically developed drug has emerged to compete in the obesity treatment market, which is currently dominated by global pharmaceutical companies. With HanmiPharm’s efeglenatide receiving mark…